WrapManager Inc’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,113
| Closed | -$353K | – | 192 |
|
|
2025
Q2 | $353K | Sell |
5,113
-2,051
| -29% | -$140K | 0.09% | 145 |
|
|
2025
Q1 | $497K | Sell |
7,164
-810
| -10% | -$66.9K | 0.13% | 117 |
|
|
2024
Q4 | $686K | Sell |
7,974
-4,109
| -34% | -$444K | 0.18% | 101 |
|
|
2024
Q3 | $1.44M | Sell |
12,083
-2,128
| -15% | -$284K | 0.37% | 63 |
|
|
2024
Q2 | $2.03M | Sell |
14,211
-1,699
| -11% | -$225K | 0.56% | 44 |
|
|
2024
Q1 | $2.04M | Sell |
15,910
-2,854
| -15% | -$340K | 0.57% | 42 |
|
|
2023
Q4 | $1.94M | Buy |
18,764
+1,298
| +7% | +$128K | 0.57% | 50 |
|
|
2023
Q3 | $1.59M | Buy |
17,466
+5,586
| +47% | +$492K | 0.51% | 52 |
|
|
2023
Q2 | $961K | Sell |
11,880
-422
| -3% | -$34.5K | 0.29% | 77 |
|
|
2023
Q1 | $979K | Sell |
12,302
-3,702
| -23% | -$263K | 0.3% | 80 |
|
|
2022
Q4 | $1.08M | Sell |
16,004
-1,192
| -7% | -$69.9K | 0.35% | 71 |
|
|
2022
Q3 | $857K | Sell |
17,196
-1,880
| -10% | -$101K | 0.29% | 79 |
|
|
2022
Q2 | $1.06M | Sell |
19,076
-74
| -0.4% | -$4.11K | 0.33% | 64 |
|
|
2022
Q1 | $1.06M | Buy |
19,150
+596
| +3% | +$30.6K | 0.28% | 83 |
|
|
2021
Q4 | $1.04M | Buy |
18,554
+320
| +2% | +$17.3K | 0.26% | 97 |
|
|
2021
Q3 | $875K | Buy |
18,234
+6,414
| +54% | +$310K | 0.23% | 98 |
|
|
2021
Q2 | $495K | Buy |
11,820
+1,476
| +14% | +$57.2K | 0.13% | 168 |
|
|
2021
Q1 | $349K | Sell |
10,344
-5,248
| -34% | -$187K | 0.1% | 192 |
|
|
2020
Q4 | $545K | Buy |
15,592
+394
| +3% | +$13.6K | 0.16% | 142 |
|
|
2020
Q3 | $528K | Sell |
15,198
-516
| -3% | -$17.2K | 0.18% | 129 |
|
|
2020
Q2 | $514K | Sell |
15,714
-46
| -0.3% | -$1.47K | 0.19% | 124 |
|
|
2020
Q1 | $474K | Sell |
15,760
-1,620
| -9% | -$48.2K | 0.21% | 114 |
|
|
2019
Q4 | $503K | Buy |
17,380
+5,418
| +45% | +$150K | 0.16% | 140 |
|
|
2019
Q3 | $309K | Sell |
11,962
-4,348
| -27% | -$110K | 0.1% | 210 |
|
|
2019
Q2 | $416K | Buy |
16,310
+1,672
| +11% | +$41.3K | 0.13% | 169 |
|
|
2019
Q1 | $383K | Buy |
14,638
+1,062
| +8% | +$26.1K | 0.13% | 180 |
|
|
2018
Q4 | $313K | Buy |
13,576
+1,894
| +16% | +$42.1K | 0.11% | 187 |
|
|
2018
Q3 | $275K | Buy |
11,682
+670
| +6% | +$16.4K | 0.09% | 253 |
|
|
2018
Q2 | $254K | Buy |
+11,012
| New | +$262K | 0.09% | 242 |
|
Other funds holding NVO
F
WrapManager Inc's NVO Position: Q3 2025 in Review
WrapManager Inc sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 5,113 shares — an estimated $353K sold.
WrapManager Inc first reported a position in NVO in Q2 2018 and held it in 29 quarters. The position peaked at $2.04M in Q1 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- WrapManager Inc reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- WrapManager Inc sold 5,113 Novo Nordisk shares in Q3 2025, an estimated $353K.
- WrapManager Inc first reported a position in Novo Nordisk in Q2 2018 and held it in 29 quarters.
- WrapManager Inc's Novo Nordisk position peaked at $2.04M in Q1 2024.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on WrapManager Inc's 13F filing for Q3 2025, filed 10 Nov 2025.